JPRN-UMIN000005432已完成2 期
Clinical efficacy and safety of fucoidan for biochemical recurrence after radical prostatectomy - Fucoidan for prostate cancer
Dept. of Urology, Kyoto University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2012年12月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) undergoing hormonal therapy 2) suspecting of distant metastasis 3) severe comorbidities 4) during 3 mo. before attempt of fucoidan intervention, receiving any types of complementary/alternative medicine 5) inappropriate, judged by doctor
研究者
相似试验
尚未招募
4 期
Efficacy and safety of Fluticasone furoate with montelukast vs Fluticasone furoate with Cetirizine in patients with allergic rhinitisCTRI/2023/10/059253SRM institute of science and technology
招募中
不适用
The effectiveness of Fluticasone furoate for pediatric allergic rhinitis patients with nasal obstruction and sleep disturbance.allergic rhinitis, sleep disturbanceJPRN-UMIN000011740Yamaguchi University Graduate School of Medicine30
已完成
不适用
The study on the usefulness of fucoidan-containing food intake for early or unresectable advanced gastric cancer patientsearly or unresectable advanced gastric cancerJPRN-UMIN000014461Kyoto Prefectural University of Medicine30
进行中（未招募）
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDEUCTR2017-004369-29-ESGlaxoSmithKline, S.A.3,000
进行中（未招募）
1 期
Single Inhaler Triple Therapy (fluticasone furoate + vilanterol trifenatate + umeclidinium bromide) (inhaled) - COPDChronic Obstructive Pulmonary Disease (COPD) which may be called emphysema or chronic bronchitis.MedDRA version: 21.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2017-004369-29-NLGlaxoSmithKline Research & Development Limited3,341